Sharpless Official as FDA Acting Commissioner

Sharpless Official as FDA Acting Commissioner

Norman E. “Ned” Sharpless replaces Scott Gottlieb, who resigned in March.

April 8, 2019

Norman E. “Ned” Sharpless, M.D., became Acting Commissioner of Food and Drugs on the afternoon of April 5, 2019. Former Commissioner Scott Gottlieb announced his resignation in March, which became official on Friday. According to a release from American Enterprise Institute (AEI), Gottlieb is returning to AEI as a resident fellow in health policy studies. He first joined AEI in 2002, and much of his work over the years has focused on the improvement of public health through entrepreneurship and medical innovation and on the expansion of regulatory approaches to maintain patient and physician autonomy.

Sharpless was previously confirmed as the 15th director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his NCI appointment, Sharpless served as the director of the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, a position he held since January 2014.

Sharpless was a Morehead Scholar at UNC–Chapel Hill and received his undergraduate degree in mathematics. He went on to pursue his medical degree from the UNC School of Medicine, graduating with honors and distinction in 1993. He then completed his internal medicine residency at the Massachusetts General Hospital and a hematology/oncology fellowship at Dana-Farber/Partners Cancer Care, both of Harvard Medical School in Boston.

After two years on the faculty at Harvard Medical School, he joined the faculty of the UNC School of Medicine in the Departments of Medicine and Genetics in 2002. He became the Wellcome Professor of Cancer Research at UNC in 2012.